Aoife Brennan insider trades

Open-market stock purchases and sales by Aoife Brennan, President and CEO at Climb Bio, Inc, from SEC Form 4 filings since Mar 14, 2018.

Recent trades

DateStockTradeValue
Jun 29, 2026CLYM Climb Bio, IncSold$407K
Jun 27, 2026CLYM Climb Bio, IncBought (not open market)—
Jun 11, 2026XLO Xilio Therapeutics, IncBought (not open market)—
Jan 6, 2026CLYM Climb Bio, IncBought (not open market)—

Companies traded

  • CLYM Climb Bio, Inc: 2 sales, last Jun 29, 2026
  • XLO Xilio Therapeutics, Inc: other filings, last Jun 11, 2026
  • ELYM Eliem Therapeutics, Inc: other filings, last Jun 27, 2024
  • FGEN Fibrogen Inc: 2 sales, last Jun 5, 2024
  • SYBX Synlogic, Inc: 2 sales, last Nov 10, 2023
  • RARX Ra Pharmaceuticals, Inc: other filings, last Apr 2, 2020

Get free alerts when Aoife Brennan files a new trade →